Skip to content
  • Saturday, 15 August 2026
  • 12:13 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Humanity’s Last Exam: Unpacking the Ambitious AI Benchmark Sparking Debate on General Intelligence and Safety
Data Science & Bioinformatics

Humanity’s Last Exam: Unpacking the Ambitious AI Benchmark Sparking Debate on General Intelligence and Safety

Evan Lee Salim Jul 2, 2026 0

Humanity’s Last Exam (HLE) has emerged as a formidable new benchmark designed to rigorously assess the advanced reasoning and deep…

Read More
Pharmaceutical R&D

Novo Nordisk’s Wegovy Pill Fuels Ambitious Growth Strategy Amidst Fierce Competition

Teuku Ryan May 8, 2026 0

Novo Nordisk’s groundbreaking oral semaglutide medication, branded as Wegovy, has emerged as a powerful financial engine, propelling the Danish pharmaceutical…

Read More
Laboratory Automation & Robotics

Rubedo Life Sciences Charts Ambitious Course to Reverse Skin Aging and Disease Through Targeted Senescent Cell Clearance

Lana Keisha Mar 30, 2026 0

In a significant pivot from the traditional aesthetics market, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick Beddingfield…

Read More
Science News: Empowering Public Understanding of Science Since 1921Science News, founded in 1921, continues its mission to provide accurate information on scientific advancements.Identification of CD99L2 Gene Variants as a Novel Driver of X-linked Spastic Ataxia Unlocks New Pathways in Neurodegenerative ResearchTWiV 1285: Encapsidating Viruses 2025
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ